Amaroq Ltd., a mining company focused on Greenland's mineral resources, will publish its Q3 2026 financial results on November 12, 2026. The company will also hold a webcast presentation for investors and analysts at 0900 GMT on the same day, with a recording available afterward. Amaroq operates the Nalunaq Gold mine and explores various minerals including gold, copper, nickel, and rare earth elements across Greenland. This update is important for investors tracking the company's progress in developing Greenland's mining potential.
Amaroq Ltd. Q3 2026 results notice provides context for market watchers. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 05, 2026 14:11 WIB: 59 of 83 US stocks rose today. Notable movers include CGAU at USD 21.55 (+9.89%), CLF at USD 12.76 (-9.76%), and IAUX at USD 1.41 (+8.46%).
Wolters Kluwer repurchased 499 of its ordinary shares between October 29 and November 4, 2026, spending €0.04 million at an average price of €85.06 per share. This is part of a larger 2026 share buyback program aiming to repurchase shares worth up to...
Lorenz Snacks has introduced a fleet of four autonomous, electric vehicles from Einride at its production site in Neunburg vorm Wald, Germany. These vehicles will handle in-plant transport of goods and materials, replacing diesel trucks and significa...
Futu Holdings Limited will announce its financial results for the third quarter ending September 30, 2026, on November 19 before U.S. market open. The company will host a live earnings conference call at 7:30 AM ET (8:30 PM Beijing/Hong Kong time) th...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
